Deregulated p21WAF1 overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients

Annals of Thoracic Surgery

Volumn 80, Issue 3, 2005, Pages 1007-1016

  Goan, Yih Gang ^a   Hsu, Hon Ki ^b   Chang, Huang Chou ^b   Chou, Yi Ping ^b   Chiang, Ke Hsin ^b   Cheng, Jiin Tsuey ^b  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; PROTEIN P21; PROTEIN P53;

ANEUPLOIDY; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA CONTENT; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SAMPLING; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE AMPLIFICATION; GENES, P53; GENETIC MARKERS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 23944512803     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.03.050     Document Type: Article

References (40)

1. Medical Research Council Esophageal Cancer Working Group Surgical resection with or without preoperative chemotherapy in esophageal cancer a randomized controlled trial Lancet 359 2002 1727 1733
2. S.C. Malaisrie, B. Untch, G.V. Aranha Neoadjuvant chemotherapy for locally advanced esophageal cancer experience at a single institution Arch Surg 139 2004 352 358
3. M. Watanabe, H. Kuwano, S. Tanaka Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus Cancer 85 1999 2322 2328
4. M.C. Hollstein, B. Shomer, M. Greenblatt Somatic point mutation in the p53 gene of human tumors and cell lines updated compilation Nucleic Acid Res 24 1996 141 146
5. Y. Yin, M.A. Tainsky, F.Z. Bischoff Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles Cell 70 1992 937 948
6. W.S. El-Deiry, T. Tokino, V.E. Velculescu EAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
7. J.W. Harper, G.R. Adami, N. Wei The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816
8. P. Michieli, M. Chedid, D. Lin Induction of WAF1/CIP1 by a p53-indepent pathway Cancer Res 54 1994 3391 3395
9. A.G. Casson, M. Tammemagi, S. Eskandarian p53 alterations in oesophageal cancer association with clinicopathological features, risk factors, and survival Mol Pathol 51 1998 71 79
10. K. Susumu, K. Yoshio, E. Masato The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability Am J Surg 177 1999 497 502
11. K.Y. Lam, S. Law, L. Tin The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma an analysis of 153 patients Am J Gastroenterol 94 1999 2060 2068
12. T. Seta, F. Imazeki, O. Yokosuka Expression of p53 and p21 WAF1/Cip1 proteins in gastric and esophageal cancers comparison with mutations of the p53 gene Dig Dis Sci 43 1998 279 289
13. K. Ohashi, T. Nemot, Y. Eishi Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in esophageal squamous cell carcinomas Virch Arch 430 1997 389 395
14. M. Sarbia, M. Stahl, A.Z. Hausen Expression of p21WAF1 predict outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities Clin Cancer Res 4 1998 2615 2623
15. Y. Shimada, M. Imamura, G. Watanabe Prognostic factors of esophageal squamous cell carcinoma from the perspective of molecular biology Br J Cancer 80 1999 1281 1288
16. G. Casey, M.E. Lopez, J.C. Ramos DNA sequence analysis of exon 2 through 11 and immunohistochemical staining are required to detect all known p53 proliferations in human malignancies Oncogene 13 1996 1971 1981
17. C. Lengauer, K. Kinzler, B. Vogelstein Genetic instabilities in human cancers Nature 396 1998 643 649
18. S. Shackney, T. Shankey Common patterns of genetic evolution in human solid tumors Cytometry 29 1997 1 27
19. H. Kuwano, K. Sumiyoshi, T. Nozoe The prognostic significance of the cytophotometric DNA content and it relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in esophageal cancer Eur J Surg Oncol 21 1995 368 373
20. S.A. Blant, J.P. Ballini, C.T.L. Caron Evolution of DNA ploidy during squamous cell carcinogenesis in the esophagus Dis Esophagus 14 2001 178 184
21. AJCC cancer staging manual Digestive system, esophagus 5th ed 1997 Lippincott-Raven Philadelphia, PA 65 68
22. D.W. Hedley, M.L. Friedlander, I.W. Taylor Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry J Histochem Cytochem 31 1983 1333 1335
23. R.D. Brown, M.D. Linden, P. Mackowiak The effect of number of histogram events on reproducibility and variation of flow cytometric proliferation measurement Am J Clin Pathol 105 1995 696 704
24. T.V. Shankey, P.S. Rabinovich, B. Bagwell Guidelines for implementation of clinical DNA cytometry Cytometry 14 1993 472 477
25. L.S. Wang, L.H. Wu, C.J. Chang Flow-cytometric DNA content analysis of esophageal carcinoma comparison between tumor and sequential non-tumor mucosa Scand Cardiovasc J 32 1998 205 212
26. J. Watanabe, H. Kuwano, S. Tanaka Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of esophagus Cancer 85 1999 2322 2328
27. Hu Fahn, L.S. Wang, B.S. Huang Tumor recurrence in long-term survivors following treatment of carcinoma of the esophagus Ann Thorac Surg 57 1994 677 681
28. T. Bottger, S. Storkel, M. Stockle DNA image cytometry. A prognostic tool in squamous cell carcinoma of the esophagus? Cancer 67 1991 2290 2294
29. R. Nowak A new test gives early warning of a growing killer Science 264 1994 1847 1848
30. M. Shiohara, W.S. El-Deiry, M. Wada Absence of WAF1 mutations in a variety of human malignancies Blood 84 1994 3781 3784
31. M.E. Nita, H. Nagawa, O. Tominaga p21WAF1/CIP1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb Ann Surg Oncol 6 1999 481 488
32. D. Guner, I. Sturm, P. Hemmatt Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis Int J Cancer 103 2003 445 454
33. D.A. Rigberg, S.K. Frances, T.A. Blinman p21 expression in increased by irradiation in esophageal squamous cell carcinoma J Surg Res 76 1998 137 142
34. W.P. Bennett, M.C. Hollstein, R.A. Metcalf P53 mutation and protein accumulation during multistage human esophageal carcinogenesis Cancer Res 52 1992 6092 6097
35. D. Wynford-Thomas p53 in tumor pathology can we trust immunocytochemistry? J Pathol 166 1992 329 330
36. B.D. Chang, K. Watanabe, E.V. Broude Effect of p21WAF1/CIP1/Sdi1 on cellular gene expression implications for carcinogenesis, senescence, and age-related diseases Proc Natl Acad Sci USA 97 2000 4291 4296
37. Z.Q. Pan, J.T. Reardon, L. Li Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21 J Biol Chem 270 1995 22008 22016
38. B.D. Chang, E.V. Broude, J. Fang p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells Oncogene 19 2000 2165 2170
39. Y. Shirakawa, Y. Naomoto, M. Kimura Topological analysis of p21WAE1/CIP1 expression in esophageal squamous dysplasia Clin Cancer Res 6 2000 541 550
40. J. Kukreja, M.T. Jaklitsh Selective use of neoadjuvant therapy Semin Thorac Cardiovasc Surg 15 2003 187 196